- $27.07bn
- $25.95bn
- $4.66bn
FDA clears first over-the-counter glucose monitor for children
Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers
Brief: Dexcom Says Use Of Dexcom G7 Leads To Improvement In Glucose Control In People With Type 2 Diabetes Not Using Insulin Versus Routine Care Control Group
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study
Brief: Signos Raises $20 Million Investment From Google Ventures, Dexcom, Blue Cross Blue Shield Of Alabama
Dexcom warns patients as stolen glucose sensors hit the market
Dexcom falls after warning stolen glucose sensors sold to patients
Brief: Dexcom Uncovers Theft Of Scrapped Product, Notifies Potentially Impacted Users
Nordic Semi falls as Dexcom filing raises dual-sourcing concerns
U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark
U.S. STOCKS ON THE MOVE-Exxon Mobil, Intel, Nvidia
Dexcom climbs on plans to revamp board panel
U.S. STOCKS ON THE MOVE-Shutterstock, RXO, Microsoft
U.S. STOCKS ON THE MOVE-Cerebras, Papa John's, airline stocks
Dexcom climbs after plans to revamp board panel with Elliott, bring 2 directors
Dexcom to appoint two directors, revamp board committee with Elliott (updated)
Dexcom to appoint two directors, revamp board committee with Elliott